Neoprobe recently filed an 8-k regarding change of directors. Our friends over at the 8k filing blog have the full story.
Neoprobe stock has been on quite a run lately from a low of about .40 to recent prices of Nearly $2. The company has a healthy cash position which is offset by their huge liabilities and negative shareholder equity. Still investors seem optimistic and have continued to bid prices higher.
